✦ LIBER ✦

Tyrosine kinase inhibitor treatments in patients with metastatic thyroid carcinomas: a retrospective study of the TUTHYREF network

✍ Scribed by Massicotte, M.-H.; Brassard, M.; Claude-Desroches, M.; Borget, I.; Bonichon, F.; Giraudet, A.-L.; Do Cao, C.; Chougnet, C. N.; Leboulleux, S.; Baudin, E.; Schlumberger, M.; de la Fouchardiere, C.

Book ID: 125449513
Publisher: Bioscientifica
Year: 2014
Tongue: English
Weight: 159 KB
Volume: 170
Category: Article
ISSN: 0804-4643
DOI: 10.1530/eje-13-0825

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Can Tyrosine Kinase Inhibitors be Discon

Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

✍ Manfred Johannsen; Anne Flörcken; Axel Bex; Jan Roigas; Marco Cosentino; Vincenz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 539 KB

Use of tyrosine kinase inhibitors in pat

Use of tyrosine kinase inhibitors in patients with metastatic kidney cancer receiving haemodialysis: a retrospective Italian survey

✍ Cristina Masini; Roberto Sabbatini; Camillo Porta; Giuseppe Procopio; Giuseppe D 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 225 KB

Editorial Comment on: Can Tyrosine Kinas

Editorial Comment on: Can Tyrosine Kinase Inhibitors be Discontinued in Patients with Metastatic Renal Cell Carcinoma and a Complete Response to Treatment? A Multicentre, Retrospective Analysis

✍ Aristotle Bamias 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Sequential Use of the Tyrosine Kinase In

Sequential Use of the Tyrosine Kinase Inhibitors Sorafenib and Sunitinib in Metastatic Renal Cell Carcinoma: A Retrospective Outcome Analysis

✍ Christian Eichelberg; Roman Heuer; Felix K. Chun; Kristin Hinrichs; Mario Zachar 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 326 KB

Assessment of health-related quality of

Assessment of health-related quality of life in Japanese patients with metastatic renal cell carcinoma during treatment with tyrosine kinase inhibitors

✍ Hideaki Miyake,Ken-ichi Harada,Taka-aki Inoue,Masato Fujisawa 📂 Article 📅 2014 🏛 Springer US 🌐 English ⚖ 287 KB

Treatment with tyrosine kinase inhibitor

Treatment with tyrosine kinase inhibitors in patients with metastatic renal cell carcinoma is associated with drug-induced hyperparathyroidism: a single center experience in 59 patients

✍ Philipp Ivanyi; Thomas Winkler; Anika Großhennig; Christoph Reuter; Axel S. Mers 📂 Article 📅 2010 🏛 Springer-Verlag 🌐 English ⚖ 389 KB